Morning Market Gainers

shares jumped 40.69 percent to $89.07 after the company agreed to be acquired by AstraZeneca plc (ADR)

for $2.7 billion.

shares surged 34.06 percent to $14.13. Lexicon Pharma reported a Q3 loss of $0.34 per share.

and Lexicon agreed to collaborate on Sotagliflozin, a potential diabetes treatment.

rose 31.65 percent to $8.07 after the company reported upbeat Q3 results.

shares climbed 25.51 percent to $95.36 on stronger-than-expected Q3 results.

shares rose 23.40 percent to $15.19 after the company reported upbeat Q3 earnings.

shares jumped 23.57 percent to $20.92 after the company reported upbeat Q3 results and raised its FY15 earnings forecast.

shares surged 20.19 percent to $101.43 on better-than-expected quarterly earnings.

shares gained 16.86 percent to $20.17 after the company reported better-than-expected Q3 results and raised its FY15 forecast.

shares gained 9.07 percent to $26.58 after the company agreed to be acquired by

for $27.60 per ADS share in cash.

shares rose 8.88 percent to $30.17 after the company reported upbeat results for the third quarter.

shares surged 5.33 percent to $19.75. Relypsa reported a Q3 loss of $1.24 per share and announced new employment inducement grants. Guggenheim Securities initiated coverage on Relypsa with a Buy rating and a $46.00 price target.

shares jumped 5.23 percent to $43.44 after surging 17.91 percent on Thursday.